logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Duncan Wheatley

Royal Cornwall Hospital Trust
H指数:34
被引数:8,573

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial☆

在PARSIFAL试验中，对内分泌敏感、激素受体阳性/HER2阴性晚期乳腺癌患者使用palbociclib联合fulvestrant或letrozole的延长随访研究☆

ESMO Open
IF8.3
2025-07-010
PRE
A. Llombart-Cussac; J.M. Pérez-García; M. Bellet; F. Dalenc; M. Gil-Gil; M. Ruiz-Borrego; J. Gavila; P. Schmid; P. Zamora; D. Wheatley; E. Martínez-de Dueñas; K. Amillano; S. Di Cosimo; A. Anton; P. Cottu; E. Shimizu; M. Fernandez; M. Sampayo-Cordero; J. Cortés
Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial

早期乳腺癌女性保乳手术后的部分乳腺放射治疗（UK IMPORT LOW）：一项多中心、开放标签、随机对照、III期非劣效性试验的10年结果

lancet oncology
IF0
2025-06-110
OA
Anna M Kirby; Laura Finneran; Clare L Griffin; Adrian M Brunt; Fay H Cafferty; Abdulla Alhasso; Charlie Chan; Joanne S Haviland; Monica L Jefford; Elinor J Sawyer; Mark A Sydenham; Isabel Syndikus; Yat M Tsang; Duncan Wheatley; John R Yarnold; Charlotte E Coles; Judith M Bliss
Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study

患者和临床医生评估的五年正常组织效应：比较乳腺癌患者接受一周期与三周期腋窝放疗的结果——来自III期FAST-Forward试验随机淋巴结亚组研究

RADIOTHERAPY AND ONCOLOGY
IF5.3
2025-06-010
OAAI
Brunt, A. Murray; Cafferty, Fay H.; Wheatley, Duncan; Sydenham, Mark A.; Kirby, Anna M.; Coles, Charlotte E.; Patel, Jaymini; Alhasso, Abdulla; Chan, Charlie; Cleator, Susan; Fleming, Helen; Gahir, Daljit; Goodman, Andy; Griffin, Clare; Haviland, Joanne S.; Kirwan, Cliona; Nabi, Zohal; Poole, Karen; Sawyer, Elinor; Sinclair, Judith; Somaiah, Navita; Syndikus, Isabel; Venables, Karen; Yarnold, John; Bliss, Judith M.
Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer
BREAST CANCER RESEARCH AND TREATMENT
IF3
2024-10-181
OAAI
Garcia-Murillas, Isaac; Cutts, Rosalind J.; Walsh-Crestani, Giselle; Phillips, Edward; Hrebien, Sarah; Dunne, Kathryn; Sidhu, Kally; Daber, Robert; Hubert, Benjamin; Graybill, Chiharu; Deford, Peter M.; Wooten, David J.; Zhao, Jianhua; Ellsworth, Rachel E.; Johnston, Stephen R. D.; Ring, Alistair; Russell, Simon; Evans, Abigail; Skene, Anthony; Wheatley, Duncan; Smith, Ian E.; Korn, W. Michael; Turner, Nicholas C.
Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer
BREAST
IF7.9
2024-08-010
OAAI
Di Cosimo, Serena; Perez-Garcia, Jose Manuel; Bellet, Meritxell; Dalenc, Florence; Gil, Miguel J. Gil; Ruiz-Borrego, Manuel; Gavila, Joaquin; Aguirre, Elena; Schmid, Peter; Marme, Frederik; Gligorov, Joseph; Schneeweiss, Andreas; Albanell, Joan; Zamora, Pilar; Wheatley, Duncan; de Duenas, Eduardo Martinez; Amillano, Kepa; Shimizu, Eileen; Sampayo-Cordero, Miguel; Cortes, Javier; Llombart-Cussac, Antonio
PARSIFAL-LONG: Extended follow-up of hormone receptor-positive/ HER2-negative advanced breast cancer patients treated with fulvestrant and palbociclib vs. letrozole and palbociclib in the PARSIFAL study
CANCER RESEARCH
IF16.6
2024-05-022
PRE
Llombart-Cussac, Antonio; Perez-Garcia, Jose Manuel; Bellet-Ezquerra, Meritxell; Dalenc, Florence; Gil-Gil, Miguel; Ruiz-Borrego, Manuel; Gavila, Joaquin; Schmid, Peter; Zamora, Pilar; Wheatley, Duncan; Martinez-de Duenas, Eduardo; Amillano, Kepa; Anton, Antonio; Cottu, Paul; Vinas, Gemma; Petit, Thierry; Tesarova, Petra; Cueva, Juan; Colleoni, Marco; del Prado, Maria Purificacion Martinez; Andres, Raquel; Cabo, Marta Diaz; Victorino, Susana; Sampayo-Cordero, Miguel; Cortes, Javier
Tracking triple negative breast cancer (TNBC) evolution in the molecular residual disease (MRD) setting in the c-TRAK TN clinical trial
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Coakley, Maria; Cutts, Rosalind J.; Sritharan, Prithika; Hrebien, Sarah; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Villacampa, Guillermo; Rojas, Patricia; Emmett, Warren; Pipinikas, Christodoulos; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Bliss, Judith M.; Garcia-Murillas, Isaac; Turner, Nicholas C.
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

一周和三周大分割全乳腺放疗治疗早期乳腺癌: 快进III期RCT

HEALTH TECHNOLOGY ASSESSMENT
IF4
2023-11-017
OA
Brunt, Adrian Murray; Haviland, Joanne S.; Wheatley, Duncan A.; Sydenham, Mark A.; Bloomfield, David J.; Chan, Charlie; Cleator, Suzy; Coles, Charlotte E.; Donovan, Ellen; Fleming, Helen; Glynn, David; Goodman, Andrew; Griffin, Susan; Hopwood, Penelope; Kirby, Anna M.; Kirwan, Cliona C.; Nabi, Zohal; Patel, Jaymini; Sawyer, Elinor; Somaiah, Navita; Syndikus, Isabel; Venables, Karen; Yarnold, John R.; Bliss, Judith M.
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial

癌症患者中血栓素的生物合成及其受阿司匹林抑制：Add-Aspirin试验的一项子研究

BRITISH JOURNAL OF CANCER
IF6.8
2023-07-0713
OA
Joharatnam-Hogan, Nalinie; Hatem, Duaa; Cafferty, Fay H.; Petrucci, Giovanna; Cameron, David A.; Ring, Alistair; Kynaston, Howard G.; Gilbert, Duncan C.; Wilson, Richard H.; Hubner, Richard A.; Swinson, Daniel E. B.; Cleary, Siobhan; Robbins, Alex; MacKenzie, Mairead; Scott-Brown, Martin W. G.; Sothi, Sharmila; Dawson, Lesley K.; Capaldi, Lisa M.; Churn, Mark; Cunningham, David; Khoo, Vincent; Armstrong, Anne C.; Ainsworth, Nicola L.; Horan, Gail; Wheatley, Duncan A.; Mullen, Russell; Lofts, Fiona J.; Walther, Axel; Herbertson, Rebecca A.; Eaton, John D.; O'Callaghan, Ann; Eichholz, Andrew; Kagzi, Mohammed M.; Patterson, Daniel M.; Narahari, Krishna; Bradbury, Jennifer; Stokes, Zuzana; Rizvi, Azhar J.; Walker, Georgina A.; Kunene, Victoria L.; Srihari, Narayanan; Gentry-Maharaj, Aleksandra; Meade, Angela; Patrono, Carlo; Rocca, Bianca; Langley, Ruth E.
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
BREAST CANCER RESEARCH AND TREATMENT
IF3
2023-03-027
OAAI
Oswald, Ailsa J.; Symeonides, Stefan N.; Wheatley, Duncan; Chan, Stephen; Brunt, Adrian Murray; McAdam, Karen; Schmid, Peter; Waters, Simon; Poole, Christopher; Twelves, Chris; Perren, Timothy; Bartlett, John; Piper, Tammy; Chisholm, Eve Macdonald; Welsh, Michelle; Hill, Robert; Hopcroft, Lisa E. M.; Barrett-Lee, Peter; Cameron, David A.
Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial
CANCER RESEARCH
IF16.6
2023-03-011
PRE
Coakley, Maria; Sritharan, Prithika; Villacampa, Guillermo; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Rojas, Patricia; Joad, Andy; Emmett, Warren; Knape, Charlene; Howarth, Karen; Hall, Peter S.; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia F.; Wardley, Andrew M.; Wheatley, Duncan; Waters, Simon; Cutts, Rosalind; Garcia-Murillas, Isaac; Bliss, Judith; Turner, Nicholas
Impact of Proton Pump Inhibitors (PPI) on Palbociclib (PAL) Outcomes in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer (HR+/HER2-ABC): Exploratory Analysis of the PARSIFAL Trial
CANCER RESEARCH
IF16.6
2023-03-011
PRE
Di Cosimo, Serena; Perez-Garcia, Jose Manuel; Ezquerra, Meritxell Bellet; Dalenc, Florence; Gil, Miguel Gil; Borrego, Manuel Ruiz; Gavila, Joaquin; Sampayo-Cordero, Miguel; Aguirre, Elena; Schmid, Peter; Marme, Frederik; Gligorov, Joseph; Schneeweiss, Andreas; Albanell, Joan; Zamora, Pilar; Wheatley, Duncan; De Duenas, Eduardo Martinez; Caranana, Vicente; Amillano, Kepa; Malfettone, Andrea; Cortes, Javier; Llombart-Cussac, Antonio
A preoperative window-of-opportunity study of imlunestrant in estrogen receptor-positive, HER2-negative early breast cancer: Results from the EMBER-2 study
CANCER RESEARCH
IF16.6
2023-03-013
PRE
Neven, Patrick; Stahl, Nicole; Vidal, Maria; Martin, Miguel; Harbeck, Nadia; Kaufman, Peter A.; Bidard, Francois-Clement; Fasching, Peter A.; Aftimos, Philippe; Hamilton, Erika; Carter, Stacey; Schmid, Peter; Wheatley, Duncan; Bhave, Manali; Hunt, Kelly K.; Kulkarni, Swati A.; Ismail-Khan, Roohi; Karacsonyi, Claudia; Estrem, Shawn T.; Ozbek, Umut; Nguyen, Bastien; Ciruelos, Eva

研究方向

暂未获取到该数据
J
Judith M. Bliss
H 指数:90论文数:805被引数:3.8万
A
Adrian Murray Brunt
H 指数:25论文数:130被引数:5,441
J
Joanne Haviland
H 指数:44论文数:205被引数:1.1万
J
John Yarnold
H 指数:66论文数:341被引数:1.9万
C
Charlotte E. Coles
H 指数:50论文数:245被引数:1.0万
M
Mark Sydenham
H 指数:24论文数:72被引数:8,173
N
Nicholas C. Turner
H 指数:92论文数:1,157被引数:4.5万
I
Iain R. Macpherson
H 指数:38论文数:295被引数:7,084
A
Andrew Wardley
H 指数:53论文数:323被引数:1.9万
S
Simon Waters
H 指数:21论文数:79被引数:2,843